Evidence map›Paper›PMID 24124228›Full record

ArticleCancer discovery2013

Are short telomeres predictive of advanced cancer?

Jerry W Shay

Abstract read
In one paragraph

Article in Cancer discovery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Telomerase gene therapy: a remission toward cancer.Medical oncology (Northwood, London, England) · 2022
    Review
  7. Review
  8. Article
  9. Regulation of Gene Expression by Telomere Position Effect.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. TERT promoter mutation in adult granulosa cell tumor of the ovary.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2018
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jerry W ShayDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas.

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V. · 1996 to 2024
$57.4M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Cell Biology Research Improvements and RenovationsC06RR030414 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI FITZ, JOHN GREGORY · 2010 to 2010
$15.0M
Cancer Biology Training GrantT32CA124334 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAY, JERRY WILLIAM · 2007 to 2021
$5.3M
The Role of Telomeres and Telomerase in CancerR13CA113094 · NCI · AMERICAN ASSOCIATION FOR CANCER RESEARCH · PI SHAY, JERRY WILLIAM · 2005 to 2005
$5k
NCI NIH HHS 5P30 CA 142543-03NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA070907NCI NIH HHS P50CA70907NCI NIH HHS R13 CA113094NCI NIH HHS T32 CA124334NCRR NIH HHS C06 RR030414NCRR NIH HHS C06 RR30414
6 · The paper itself

Abstract

The combination of variable telomere length in cancer cells and shorter telomere length in cancer-associated stromal cells strongly correlates with progression to prostate cancer metastasis and cancer death. The implication is that telomere length measurements have potential not only as prognostic indicators of prostate cancer outcomes but also as risk stratification enrichment biomarkers for individualized therapeutic interventions.

Indexed as

AnimalsBiomarkers, TumorDisease ProgressionHumansMaleNeoplasm MetastasisPrecision MedicineProstatic NeoplasmsRatsTelomereBiomarkers, Tumor

Identifiers

PMID24124228
PMCPMC4163052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.